FDA Clarifies User Fee Refund Policy, MDUFMA Performance Goals
This article was originally published in The Gray Sheet
Executive Summary
FDA's adherence to user fee performance goals will be measured by "FDA days"- the amount of time a premarket application is pending at the agency - rather than by total review times, HHS clarifies in a November presentation to Congress